Pediatrix Medical Group, Inc. MD
Pediatrix Medical Group, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($21.03); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Pediatrix Medical Group, Inc. trades at about 13.7× earnings — below its 10-year norm (10-year range 11×–21.3×, median 19.4×).
Shaded band = 10-year range (11×–21.3×); dot = today's 13.7×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 10.9% | -3.4% | 0.4% | 8.8% | 10.6% | 5.7% | 9.7% | 14.4% | 14.0% | 18.0% |
| Net margin | 8.6% | -4.9% | -3.0% | 3.4% | 6.9% | -45.9% | -84.2% | 15.6% | 9.8% | 10.2% |
| Return on assets | 7.4% | -4.6% | -2.7% | 2.8% | 4.8% | -23.8% | -36.1% | 4.5% | 5.5% | 6.1% |
| Return on equity | 19.1% | -13.0% | -7.1% | 7.4% | 14.6% | -106.5% | -99.9% | 8.7% | 10.4% | 11.8% |
| Debt / equity | — | 0.80× | 0.73× | 0.71× | 1.10× | 2.27× | 1.13× | 0.64× | 0.60× | 0.62× |
| Current ratio | 1.66 | 1.47 | 1.24 | 1.00 | 1.97 | 3.49 | 1.35 | 1.31 | 1.18 | 1.31 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.